The Use of Cervical Length to Reduce Hospital Stay in Women Admitted Because of Preterm Labor.
NCT00432250
Cervical Length, Female Urogenital Diseases and Pregnancy Complications
Sabino de Arana 1, Barcelona, Spain
View Trial DetailsNCT Number: NCT04922671
This is a prospective study where pregnant women between 16-24 weeks gestation attending the Antenatal Clinic, Fetomaternal clinic or Obstetrics & Gynaecology Admission Centre (OGAC) at Hospital Serdang or Hospital Pengajar UPM will be recruited. BMI will be taken both during booking of pregnancy and at recruitment. Cervical length will be measured via transvaginal scan at recruitment time. We aim to assess the association between body mass index, cervical length and risk of preterm birth.
Looking for future studies?
Notify MeFemale
Observational
Hospital Pengajar UPM, Serdang, Selangor, Malaysia
General Objective To assess the association between body mass index, cervical length and risk of preterm birth.
Specific Objectives
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: till February 2023
Association of BMI and CL
Time frame: till February 2023
Value leading to high risk of spontaneous preterm birth among Malaysian women
Time frame: till February 2023
Association of CL and PTB
Time frame: till February 2023
Association of BMI and PTB
Time frame: Till May 2023
Attributable risk of preterm birth with relation to BMI and CL
Universiti Putra Malaysia
Other
Towards Development of an Individualised Screening Tool By Utilising Cervical Length Measurement In Relation To Body Mass Index (BMI) For Early Identification And Intervention Of Preterm Birth
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00432250
Cervical Length, Female Urogenital Diseases and Pregnancy Complications
Sabino de Arana 1, Barcelona, Spain
View Trial DetailsNCT07208552
Bishop Score, Cervical Length
View Trial DetailsNCT07695467
Female Urogenital Diseases and Pregnancy Complications, Obstetric Labor Complications
Sivas, Kayseri Ave, Turkey (Türkiye)
View Trial DetailsNCT04831086
Amniocentesis Affecting Fetus or Newborn, Female Urogenital Diseases and Pregnancy Complications
Barcelona, Spain
View Trial Details